We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

News   Jan 17, 2018 | Original story from The Salk Institute

 
The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

Salk's CSO Martin Hetzer, Cancer Center Director Reuben Shaw and Director of Business Development Tari Suprapto pictured with Indivumed's Founder and CEO Hartmut Juhl and Managing Director Andrew Deubler. Credit: Salk Institute

 
 
 

RELATED ARTICLES

Scientists Develop Platform to Kill Cancer Cells

News

For the first time ever, scientists have shown that a hybrid nanomaterial based on magnetite-gold particles can serve as a universal platform to both detect cancer cells anywhere in the body and to complete targeted deliveries of drugs to these cells.

READ MORE

Molecular Switch May Serve as New Target for Cancer and Diabetes Therapies

News

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A recently discovered mechanism has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases.

READ MORE

New Method of Diagnosing Cancer with Malaria Protein

News

Researchers have discovered a method of diagnosing a broad range of cancers at their early stages by utilizing a particular malaria protein, which sticks to cancer cells in blood samples.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE